KDOAM-25 citrate is a potent and highly selective inhibitor of histone lysine demethylase 5 (KDM5), used to increase global H3K4 methylation at transcription start sites and inhibit the proliferation of multiple myeloma MM1S cells; it induces G1 cell-cycle arrest without promoting apoptosis, and elevates H3K4me3 levels in multiple myeloma cells.